Total Funding
46
46
Total FundingSeries C raised
Growth Score 46 in past quarter
-1 pts
Heat Score 46 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
116474
Gexval is a healthcare company that helps patients and families fighting against orphan and intractable diseases.
- Takako Naito: Research Alliance, Chief, Co-Founder
- Juran Kato: President and CEO
About the Company
GEXVal is a research and development-oriented drug discovery company. The company specializes in the creation of treatments for rare and incurable diseases. The mission of GEXVal is to provide patients and families with the rare and incurable diseases with innovative, cost-effective treatment options that will enhance their health and quality of
life.